Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of Teneligliptin and Metformin XR FDC in Healthy Male Volunteers
NCT03787043Phase 1Completed
- Sponsor
- Handok
- Start
- May 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of teneligliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Handok. Primary endpoints: Area Under the Curve of MP-513 and Metformin at 72 hours and Maximum Observed Concentration of MP-513 and Metformin at 72 hours. Started May 2014; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03787043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03787043.